Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience.
Journal: European heart journal. Acute cardiovascular care
Published: August 04, 2016
Impact of intraprocedural stent thrombosis during percutaneous coronary intervention: insights from the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention).
Journal: Journal of the American College of Cardiology
Published: October 14, 2013
Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery.
Journal: The heart surgery forum
Published: April 30, 2013
Effect of platelet inhibition with cangrelor during PCI on ischemic events.
Journal: The New England journal of medicine
Published: March 12, 2013
Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: insights from the CHAMPION percutaneous coronary intervention trial.
Journal: Coronary artery disease
Published: February 28, 2013
Rationale and design of the Cangrelor versus standard therapy to acHieve optimal Management of Platelet InhibitiON PHOENIX trial.
Journal: American heart journal
Published: December 13, 2011
Showing 1-6 of 6
Last Updated: 09/26/2026